Skip to main content
Equibles
ACAD logo

ACAD · Acadia Pharmaceuticals Inc · Proposed Sales

Track ACAD — free

Use ACAD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ACAD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$20.15 -0.07 (-0.35%) At close · Sep 30
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$3.44B
Shares
172.31M
Volume · Sep 30 3.13M Avg daily vol (3M) 1.77M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-08-05 Schneyer Mark C. 5,849
2026-06-26 Kihara James 11,421
2026-05-26 JAMES K KIHARA 5,401
2025-11-10 James M Daly 30,000
2025-08-18 Schneyer Mark C. 22,000
2025-06-04 LAURA BREGE 14,446
2025-05-16 Schneyer Mark C. 2,000
2025-05-16 Kihara James 4,000
2025-03-06 GAROFALO ELIZABETH A. 4,919
2023-12-15 Kihara James 2,000
2023-09-15 Kihara James 2,000
2023-08-21 Schneyer Mark C. 10,000
2023-07-14 DAVIS STEPHEN 100,000
2023-07-13 DAVIS STEPHEN 71,602
2023-06-15 Kihara James 2,000
2023-06-12 Brege Laura 4,500
Showing 1–16 of 16 filings
Key facts CIK 1070494 CUSIP 004225108 13F (30d) 14 filings 11 filers Visit website Investor relations